US Bancorp
ALDX icon

US Bancorp’s Aldeyra Therapeutics ALDX Stock Holding History

US Bancorp’s Portfolio ALDX Stock Details ALDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-554
Closed -$2.89K – 4042
2025
Q3 		$2.89K Sell
554
-20,582
-97% -$107K ﹤0.01% 3697
2025
Q2 		$81K Buy
21,136
+21,112
+87,967% +$54.6K ﹤0.01% 2542
2025
Q1 		$138 Buy
+24
New +$142 ﹤0.01% 4125
2024
Q4 		– Sell
-5,578
Closed -$30.1K – 4159
2024
Q3 		$30.1K Buy
+5,578
New +$26.6K ﹤0.01% 2972

Other funds holding ALDX

KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
PA
Perceptive Advisors New York $5.06B AUM 314.02% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
KCM
Kingdon Capital Management New York $597M AUM 51.11% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return
6CM
683 Capital Management New York $1.08B AUM 85.52% 1-Year Est. Return
AAP
Ardsley Advisory Partners Stamford, Connecticut $921M AUM 207.76% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return